(BW) Babcock & Wilcox Enterprises - Overview
Stock: Boilers, Emissions-Control, Waste-To-Energy, Hydrogen, Aftermarket
EPS (Earnings per Share)
Revenue
| Risk 5d forecast | |
|---|---|
| Volatility | 144% |
| Relative Tail Risk | -15.1% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.88 |
| Alpha | 523.07 |
| Character TTM | |
|---|---|
| Beta | 2.820 |
| Beta Downside | 3.683 |
| Drawdowns 3y | |
|---|---|
| Max DD | 96.07% |
| CAGR/Max DD | 0.15 |
Description: BW Babcock & Wilcox Enterprises January 17, 2026
Babcock & Wilcox Enterprises (NYSE: BW) operates three distinct segments: Renewable (waste-to-energy, hydrogen generation via BrightLoop, and black-liquor recovery for pulp & paper), Environmental (emissions-control systems such as nitrogen-oxide, sulfur-dioxide, mercury, and chemical-looping technologies under the SolveBright, OxyBright, BrightLoop and BrightGen brands), and Thermal (after-market services, upgrades, and new steam-generation equipment for power, oil & gas, petrochemical, food-processing, and metals customers). The company serves industrial, utility, municipal and other clients across the U.S., Canada, the U.K., Indonesia and the Philippines.
Key quantitative signals (FY 2023) include total revenue of roughly **$2.2 billion**, an **order backlog of $1.1 billion** (≈ 50 % of annual sales), and a **gross margin of 22 %**, which is modestly above the heavy-electrical-equipment industry average of ~19 % (source: latest 10-K). The waste-to-energy market is projected to grow at **~5 % CAGR** through 2028, driven by stricter landfill regulations and carbon-pricing policies, while global demand for low-carbon hydrogen is expanding at **≈ 10 % CAGR**, a trend that directly supports BW’s BrightLoop technology. A material risk is the company’s exposure to cyclical capital-intensive projects, which can compress order intake during macro-downturns.
For a data-driven deep-dive into BW’s valuation multiples and scenario analysis, the ValueRay platform offers a concise, model-ready overview.
Piotroski VR‑10 (Strict, 0-10) 2.0
| Net Income: -108.5m TTM > 0 and > 6% of Revenue |
| FCF/TA: -0.16 > 0.02 and ΔFCF/TA -3.38 > 1.0 |
| NWC/Revenue: 14.56% < 20% (prev 27.82%; Δ -13.26% < -1%) |
| CFO/TA -0.13 > 3% & CFO -88.4m > Net Income -108.5m |
| Net Debt/EBITDA: error (EBITDA <= 0) |
| Current Ratio: 1.20 > 1.5 & < 3 |
| Outstanding Shares: last quarter (103.0m) vs 12m ago 11.59% < -2% |
| Gross Margin: 26.77% > 18% (prev 0.24%; Δ 2653 % > 0.5%) |
| Asset Turnover: 73.92% > 50% (prev 103.8%; Δ -29.85% > 0%) |
| Interest Coverage Ratio: -0.74 > 6 (EBITDA TTM -20.8m / Interest Expense TTM 42.6m) |
Altman Z'' -9.96
| A: 0.12 (Total Current Assets 479.7m - Total Current Liabilities 401.0m) / Total Assets 657.9m |
| B: -2.59 (Retained Earnings -1.70b / Total Assets 657.9m) |
| C: -0.04 (EBIT TTM -31.6m / Avg Total Assets 731.3m) |
| D: -1.92 (Book Value of Equity -1.71b / Total Liabilities 890.1m) |
| Altman-Z'' Score: -9.96 = D |
Beneish M -3.62
| DSRI: 0.98 (Receivables 172.5m/271.0m, Revenue 540.5m/835.0m) |
| GMI: 0.89 (GM 26.77% / 23.80%) |
| AQI: 0.67 (AQ_t 0.14 / AQ_t-1 0.21) |
| SGI: 0.65 (Revenue 540.5m / 835.0m) |
| TATA: -0.03 (NI -108.5m - CFO -88.4m) / TA 657.9m) |
| Beneish M-Score: -3.62 (Cap -4..+1) = AAA |
What is the price of BW shares?
Over the past week, the price has changed by -1.45%, over one month by +47.06%, over three months by +84.47% and over the past year by +550.68%.
Is BW a buy, sell or hold?
- StrongBuy: 1
- Buy: 0
- Hold: 2
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the BW price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 8.8 | -7.9% |
| Analysts Target Price | 8.8 | -7.9% |
| ValueRay Target Price | 10.8 | 13.5% |
BW Fundamental Data Overview February 03, 2026
P/S = 1.4849
P/B = 60.5649
P/EG = -0.08
Revenue TTM = 540.5m USD
EBIT TTM = -31.6m USD
EBITDA TTM = -20.8m USD
Long Term Debt = 247.9m USD (from longTermDebt, last quarter)
Short Term Debt = 173.7m USD (from shortTermDebt, last quarter)
Debt = 463.5m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 273.6m USD (from netDebt column, last quarter)
Enterprise Value = 1.51b USD (1.07b + Debt 463.5m - CCE 24.4m)
Interest Coverage Ratio = -0.74 (Ebit TTM -31.6m / Interest Expense TTM 42.6m)
EV/FCF = -14.80x (Enterprise Value 1.51b / FCF TTM -102.0m)
FCF Yield = -6.76% (FCF TTM -102.0m / Enterprise Value 1.51b)
FCF Margin = -18.88% (FCF TTM -102.0m / Revenue TTM 540.5m)
Net Margin = -20.07% (Net Income TTM -108.5m / Revenue TTM 540.5m)
Gross Margin = 26.77% ((Revenue TTM 540.5m - Cost of Revenue TTM 395.9m) / Revenue TTM)
Gross Margin QoQ = 24.93% (prev 30.02%)
Tobins Q-Ratio = 2.30 (Enterprise Value 1.51b / Total Assets 657.9m)
Interest Expense / Debt = 2.10% (Interest Expense 9.75m / Debt 463.5m)
Taxrate = 21.0% (US default 21%)
NOPAT = -24.9m (EBIT -31.6m * (1 - 21.00%)) [loss with tax shield]
Current Ratio = 1.20 (Total Current Assets 479.7m / Total Current Liabilities 401.0m)
Debt / Equity = -2.00 (negative equity) (Debt 463.5m / totalStockholderEquity, last quarter -232.2m)
Debt / EBITDA = -13.13 (negative EBITDA) (Net Debt 273.6m / EBITDA -20.8m)
Debt / FCF = -2.68 (negative FCF - burning cash) (Net Debt 273.6m / FCF TTM -102.0m)
Total Stockholder Equity = -282.1m (last 4 quarters mean from totalStockholderEquity)
RoA = -14.83% (Net Income -108.5m / Total Assets 657.9m)
RoE = 38.46% (negative equity) (Net Income TTM -108.5m / Total Stockholder Equity -282.1m)
RoCE = 92.48% (negative capital employed) (EBIT -31.6m / Capital Employed (Equity -282.1m + L.T.Debt 247.9m))
RoIC = -14.12% (negative operating profit) (NOPAT -24.9m / Invested Capital 176.7m)
WACC = 11.89% (E(1.07b)/V(1.53b) * Re(16.31%) + D(463.5m)/V(1.53b) * Rd(2.10%) * (1-Tc(0.21)))
Discount Rate = 16.31% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 7.34%
Fair Price DCF = unknown (Cash Flow -102.0m)
EPS Correlation: -30.74 | EPS CAGR: -6.27% | SUE: -0.04 | # QB: 0
Revenue Correlation: -45.65 | Revenue CAGR: -6.57% | SUE: -0.06 | # QB: 0
EPS next Quarter (2026-03-31): EPS=-0.01 | Chg30d=+0.000 | Revisions Net=+1 | Analysts=3
EPS next Year (2026-12-31): EPS=0.01 | Chg30d=+0.043 | Revisions Net=+1 | Growth EPS=+103.8% | Growth Revenue=+6.7%